Thalassaemia treatment gets EU approval
New data from Parkinson’s disease trial
Restoring the “longevity protein”
Positive topline results from phase 2 recurrent ovarian cancer trial
Montreal biotech LifeLore Pathways launches to accelerate microbial innovation
Positive phase III results for idiopathic nephrotic syndrome drug
A new era in Alzheimer’s therapy?
China’s first AI drug completes phase III trial
Hopes for anti-ulcer vaccine
Lilly to acquire Adverum Biotechnologies
Advances in cell therapy for Huntington’s disease treatment
Custom-designed receptors boost cancer-fighting T cells